FY2027 EPS Estimates for Doximity Boosted by Leerink Partnrs

Doximity, Inc. (NASDAQ:DOCS - Free Report) - Leerink Partnrs boosted their FY2027 earnings estimates for shares of Doximity in a report released on Monday, March 3rd. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings per share of $1.33 for the year, up from their prior estimate of $1.31. Leerink Partnrs has a "Strong-Buy" rating on the stock. The consensus estimate for Doximity's current full-year earnings is $0.99 per share. Leerink Partnrs also issued estimates for Doximity's FY2028 earnings at $1.47 EPS.

A number of other equities research analysts have also commented on the company. Bank of America raised their price objective on Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Canaccord Genuity Group downgraded shares of Doximity from a "buy" rating to a "hold" rating and boosted their price objective for the company from $40.00 to $60.00 in a research report on Wednesday, November 13th. Stephens initiated coverage on shares of Doximity in a research note on Friday, December 20th. They set an "equal weight" rating and a $55.00 target price for the company. Leerink Partners raised shares of Doximity from a "market perform" rating to an "outperform" rating and upped their price target for the stock from $60.00 to $90.00 in a research note on Friday, February 7th. Finally, Mizuho increased their price objective on Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $64.22.

Remove Ads

Doximity Stock Performance

Shares of DOCS stock traded down $1.87 on Tuesday, reaching $64.09. 1,919,244 shares of the company's stock traded hands, compared to its average volume of 2,433,665. The company has a market capitalization of $11.96 billion, a P/E ratio of 64.09, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity has a 12-month low of $22.96 and a 12-month high of $85.21. The business's 50 day moving average price is $62.68 and its two-hundred day moving average price is $51.41.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 37.40% of the company's stock.

Institutional Trading of Doximity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DOCS. Global Retirement Partners LLC boosted its position in shares of Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after acquiring an additional 440 shares during the period. UMB Bank n.a. raised its stake in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Farther Finance Advisors LLC boosted its holdings in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after purchasing an additional 603 shares during the period. Larson Financial Group LLC grew its position in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after purchasing an additional 250 shares during the last quarter. Finally, Optimum Investment Advisors bought a new position in shares of Doximity during the 4th quarter worth about $43,000. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.